Peptide blends: one vial, no shared evidence
Blends combine two or more peptides in one vial. A study of one compound says nothing about a mix, so a blend has only the evidence from studies of that blend. If you searched for “peptide stack”, this is the page for it; we use the word blend.
- Evidence grade or review status for every compound
- Sources listed on every page
- US and sport status, dated
Blends combine two or more peptides in one vial. A study of one compound says nothing about a mix, so a blend has only the evidence from studies of that blend. No controlled human study has tested BPC-157 with TB-500 or CJC-1295 with ipamorelin, and we found no published study, in any species, of the mixes sold as GLOW or KLOW.
Compounds studied in this area
Grades describe the published evidence, not a promise of any effect.
Does research on single peptides apply to blends?
Evidence attaches to what was studied. A study of one compound says nothing about a pair or a blend, so each compound is graded on its own.
People often cite two 2006 placebo-controlled studies for "CJC-1295 with ipamorelin". Both tested CJC-1295 alone, in the long-acting form the paper describes; they did not test forms sold as "no DAC". Ipamorelin's human studies also tested it on its own. No human study tested the pair. [1] [5] [2] [6] [4]
We found no published study, in any species, that tested the mixes sold as GLOW or KLOW. [4]
The blends people ask about
The "Wolverine" blend
A name sellers use for a blend, not a compound. Each ingredient is graded on its own, and no controlled human study has tested BPC-157 and TB-500 together. Only a lab report for that batch shows what was in the tested sample.
Recovery researchGLOW and KLOW blends
We found no published study, in any species, that tested the mixes sold under these names. The topical evidence for GHK-Cu does not carry over to a mixed vial.
Skin researchCJC-1295 + ipamorelin
The two 2006 placebo-controlled studies often cited for the pair tested CJC-1295 alone, in the long-acting form the paper describes; they did not test forms sold as "no DAC". Ipamorelin's human studies also tested it on its own. No human study tested the pair. Both are named on WADA's 2026 Prohibited List (S2).
Peptides in sportHow far has the research on each ingredient gone?
Pick a compound to see the highest rung reached, from cell study to approval.
What doesn’t the research on peptide blends show?
Saying what we don't know is part of the evidence.
Any effect of a blend in people: no controlled human study has tested any of the mixes on this page.
That a blend is equivalent to its parts: stability and purity in a mixed vial are separate questions for the lab report.
Are BPC-157, TB-500 and GHK-Cu FDA-approved medicines? US and sport status
As of November 2026. See the full tracker and the changelog.
| Compound | FDA approval | 503A compounding (2026) | WADA (2026 List) |
|---|---|---|---|
| BPC-157 | Not approved | FDA advisory committee voted for listing (Jul); HHS enforcement-discretion policy (Oct); no rule yet | Prohibited (S0, named) |
| TB-500 | Not approved | FDA advisory committee voted for listing (Jul); HHS enforcement-discretion policy (Oct); no rule yet | Prohibited (S2, named) |
| GHK-Cu | Not approved | Injectable form formerly FDA Category 2; nomination withdrawn (FDA list, current 22 Apr 2026); not in the July review | Not named; S0 covers unapproved substances |
Worth knowing
Research use only
None of the compounds on this page is an FDA-approved medicine. Nothing on this page is medical advice or describes use in people.
What research use only meansNo doses, ever
We publish no doses, protocols, or cycles for people, on any page.
Why we publish no dosesHow we grade evidence
Grades follow study design: cell and animal studies (preclinical), small human studies, then controlled human trials, with approval tracked separately. A grade is not a promise of any effect.
Evidence gradesQuestions people ask
Is there evidence for the Wolverine blend?
Not in people. Each compound in a blend is graded on its own, and no controlled human study has tested BPC-157 and TB-500 together.
What should a lab report for a blend show?
Identity and purity for each peptide in the vial, matched to the batch number. A single purity figure for the whole mix does not tell you that.
Sources
- Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799–805. PMID 16352683. pubmed.ncbi.nlm.nih.gov/16352683/
- Gobburu JV, et al. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharm Res. 1999;16(9):1412–1416. PMID 10496658. doi.org/10.1023/A:1018955126402
- World Anti-Doping Agency. Prohibited List 2026 (in force 1 January 2026) and 2027 (in force 1 January 2027). www.wada-ama.org/en/prohibited-list
- PubMed and ClinicalTrials.gov searches for human studies of BPC-157 with TB-500 and of CJC-1295 with ipamorelin, and PubMed searches for any study of GHK-Cu with BPC-157, TB-500 or KPV, 17–18 November 2026: no controlled human study of either pair, and no study that tested the GLOW or KLOW mixes, found. pubmed.ncbi.nlm.nih.gov/?term=CJC-1295+AND+ipamorelin
- Jetté L, et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005;146(7):3052–3058. PMID 15817669. pubmed.ncbi.nlm.nih.gov/15817669/
- Beck DE, et al. Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Int J Colorectal Dis. 2014;29(12):1527–1534. PMID 25331030. pubmed.ncbi.nlm.nih.gov/25331030/
- Delcourt V, et al. TB500/TB1000 and SGF1000: a scientific approach for a better understanding of misbranded and adulterated drugs. Drug Test Anal. 2023;15(4):458–464. PMID 36482504. pubmed.ncbi.nlm.nih.gov/36482504/
Start with the evidence
Every page sourced and dated, including what the research does not show.
Open the research library